CVS Health Corporation (CVS) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 100.43B | 105.69B | 102.87B | 98.92B | 94.59B | 97.71B | 95.43B | 91.23B | 88.44B | 93.81B | 89.76B | 88.92B | 85.28B | 83.85B | 81.16B | 80.64B | 76.83B | 76.6B | 73.79B | 72.62B |
| Revenue Growth % | 6.17% | 8.17% | 7.8% | 8.42% | 6.96% | 4.15% | 6.31% | 2.6% | 3.7% | 11.89% | 10.6% | 10.27% | 11% | 9.45% | 9.98% | 11.04% | 11.19% | 10.14% | 10.05% | 11.13% |
| Cost of Goods Sold | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 15.62B | 13.57B | 13.81B | 13.59B | 14.4B | 12.9B | 12.56B | 13.38B | 12.56B | 13.88B | 13.58B | 13.6B | 13.38B | 13.81B | 13.39B | 13.86B | 13.39B | 13.65B | 12.7B | 13.2B |
| Gross Margin % | 15.56% | 12.84% | 13.42% | 13.74% | 15.22% | 13.2% | 13.16% | 14.67% | 14.2% | 14.79% | 15.13% | 15.3% | 15.68% | 16.47% | 16.5% | 17.18% | 17.43% | 17.82% | 17.21% | 18.17% |
| Gross Profit Growth % | 8.53% | 5.18% | 9.94% | 1.57% | 14.61% | -7.04% | -7.51% | -1.62% | -6.09% | 0.46% | 1.37% | -1.83% | -0.14% | 1.18% | 5.44% | 5.01% | 7.16% | 14.18% | 8.38% | -1.15% |
| Operating Expenses | 10.94B | 11.46B | 17.01B | 11.21B | 11.02B | 10.53B | 11.73B | 10.34B | 10.29B | 10.5B | 9.89B | 10.37B | 9.93B | 10.2B | 17.31B | 9.19B | 9.85B | 11.42B | 9.64B | 8.87B |
| OpEx % of Revenue | 10.9% | 10.84% | 16.54% | 11.34% | 11.65% | 10.78% | 12.29% | 11.33% | 11.64% | 11.2% | 11.01% | 11.66% | 11.64% | 12.16% | 21.33% | 11.39% | 12.82% | 14.91% | 13.06% | 12.21% |
| Selling, General & Admin | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income | 4.68B | 2.11B | -3.21B | 2.38B | 3.37B | 2.37B | 832M | 3.04B | 2.27B | 3.37B | 3.69B | 3.23B | 3.45B | 3.62B | -3.92B | 4.67B | 3.54B | 2.23B | 3.06B | 4.33B |
| Operating Margin % | 4.66% | 2% | -3.12% | 2.41% | 3.57% | 2.42% | 0.87% | 3.34% | 2.57% | 3.6% | 4.11% | 3.64% | 4.04% | 4.32% | -4.83% | 5.79% | 4.61% | 2.91% | 4.15% | 5.96% |
| Operating Income Growth % | 38.71% | -10.81% | -485.46% | -21.81% | 48.57% | -29.8% | -77.45% | -5.84% | -34.1% | -6.77% | 194.16% | -30.73% | -2.79% | 62.31% | -228.03% | 7.93% | -0.89% | -11.69% | -5.79% | -7.56% |
| EBITDA | 5.79B | 3.26B | -2.07B | 3.55B | 4.53B | 3.52B | 1.99B | 4.2B | 3.41B | 4.51B | 4.82B | 4.34B | 4.45B | 4.67B | -2.87B | 5.75B | 4.59B | 3.34B | 4.2B | 5.46B |
| EBITDA Margin % | 5.77% | 3.08% | -2.02% | 3.59% | 4.79% | 3.6% | 2.09% | 4.6% | 3.85% | 4.8% | 5.37% | 4.88% | 5.21% | 5.57% | -3.54% | 7.13% | 5.98% | 4.37% | 5.68% | 7.52% |
| EBITDA Growth % | 27.98% | -7.28% | -204.01% | -15.35% | 32.82% | -22.01% | -58.63% | -3.27% | -23.34% | -3.43% | 267.9% | -24.57% | -3.2% | 39.56% | -168.39% | 5.27% | -2.32% | -8.71% | -3.85% | -5.52% |
| D&A (Non-Cash Add-back) | 1.11B | 1.15B | 1.13B | 1.17B | 1.15B | 1.15B | 1.16B | 1.15B | 1.14B | 1.13B | 1.13B | 1.1B | 1B | 1.05B | 1.05B | 1.08B | 1.05B | 1.11B | 1.13B | 1.14B |
| EBIT | 4.71B | 2.14B | -2.7B | 2.41B | 3.4B | 2.88B | 857M | 3.07B | 2.3B | 3.4B | 3.71B | 3.26B | 3.47B | 3.66B | -3.88B | 4.71B | 3.59B | 2.18B | 2.75B | 4.37B |
| Net Interest Income | -774M | -787M | -784M | -763M | -785M | -758M | -752M | -732M | -716M | -690M | -693M | -686M | -589M | -552M | -566M | -583M | -586M | -608M | -602M | -636M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 774M | 787M | 784M | 763M | 785M | 758M | 752M | 732M | 716M | 690M | 693M | 686M | 589M | 552M | 566M | 583M | 586M | 608M | 602M | 636M |
| Other Income/Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Pretax Income | 3.94B | 1.35B | -3.48B | 1.65B | 2.62B | 2.13B | 105M | 2.34B | 1.58B | 2.71B | 3.02B | 2.57B | 2.88B | 3.11B | -4.44B | 4.13B | 3B | 1.57B | 2.15B | 3.73B |
| Pretax Margin % | 3.92% | 1.28% | -3.38% | 1.67% | 2.77% | 2.18% | 0.11% | 2.56% | 1.79% | 2.88% | 3.36% | 2.89% | 3.38% | 3.71% | -5.48% | 5.12% | 3.91% | 2.05% | 2.91% | 5.14% |
| Income Tax | 995M | -1.57B | 508M | 634M | 835M | 503M | 34M | 569M | 456M | 658M | 754M | 656M | 737M | 809M | -1.04B | 1.09B | 646M | 274M | 558M | 944M |
| Effective Tax Rate % | 25.27% | -115.88% | -14.59% | 38.49% | 31.91% | 23.66% | 32.38% | 24.35% | 28.86% | 24.33% | 24.98% | 25.53% | 25.6% | 26.02% | 23.51% | 26.4% | 21.53% | 17.45% | 26.01% | 25.27% |
| Net Income | 2.94B | 2.94B | -3.98B | 1.02B | 1.78B | 1.64B | 87M | 1.77B | 1.11B | 2.05B | 2.26B | 1.9B | 2.14B | 2.3B | -3.41B | 3.03B | 2.35B | 1.31B | 1.6B | 2.78B |
| Net Margin % | 2.93% | 2.78% | -3.86% | 1.03% | 1.88% | 1.68% | 0.09% | 1.94% | 1.26% | 2.18% | 2.52% | 2.14% | 2.5% | 2.75% | -4.2% | 3.76% | 3.06% | 1.7% | 2.17% | 3.83% |
| Net Income Growth % | 65.43% | 79.01% | -4668.97% | -42.32% | 59.84% | -19.65% | -96.15% | -6.89% | -47.89% | -11.12% | 166.38% | -37.24% | -9.26% | 76.26% | -313.14% | 8.84% | 5.89% | 34.22% | 30.56% | -6.45% |
| Net Income (Continuing) | 2.94B | 2.92B | -3.99B | 1.01B | 1.78B | 1.62B | 71M | 1.77B | 1.12B | 2.05B | 2.27B | 1.91B | 2.14B | 2.3B | -3.4B | 3.04B | 2.35B | 1.3B | 1.59B | 2.79B |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 181M | 168M | 182M | 172M | 181M | 170M | 162M | 181M | 182M | 175M | 173M | 276M | 198M | 300M | 328M | 322M | 310M | 306M | 310M | 321M |
| EPS (Diluted) | 2.30 | 2.30 | -3.13 | 0.80 | 1.41 | 1.30 | 0.07 | 1.41 | 0.88 | 1.59 | 1.75 | 1.48 | 1.65 | 1.77 | -2.59 | 2.29 | 1.77 | 0.98 | 1.20 | 2.10 |
| EPS Growth % | 63.12% | 76.92% | -4629.67% | -43.26% | 60.23% | -18.24% | -96.05% | -4.73% | -46.67% | -10.17% | 167.57% | -35.37% | -6.78% | 80.61% | -315.83% | 9.05% | 5.36% | 32.43% | 29.03% | -7.08% |
| EPS (Basic) | 2.31 | 2.32 | -3.13 | 0.81 | 1.41 | 1.31 | 0.07 | 1.41 | 0.88 | 1.59 | 1.76 | 1.48 | 1.66 | 1.78 | -2.59 | 2.31 | 1.79 | 0.99 | 1.21 | 2.11 |
| Diluted Shares Outstanding | 1.28B | 1.28B | 1.27B | 1.27B | 1.26B | 1.26B | 1.26B | 1.26B | 1.27B | 1.29B | 1.29B | 1.29B | 1.29B | 1.32B | 1.31B | 1.32B | 1.33B | 1.34B | 1.33B | 1.33B |
| Basic Shares Outstanding | 1.27B | 1.27B | 1.27B | 1.27B | 1.26B | 1.26B | 1.26B | 1.26B | 1.26B | 1.29B | 1.29B | 1.28B | 1.28B | 1.31B | 1.31B | 1.31B | 1.31B | 1.32B | 1.32B | 1.32B |
| Dividend Payout Ratio | 28.78% | 28.71% | - | 84.82% | 47.22% | 50.97% | 962.07% | 48.47% | 75.47% | 38.07% | 34.45% | 41.82% | 36.47% | 31.23% | - | 24.43% | 30.67% | 50.54% | 41.24% | 23.36% |